Starpharma Holdings Limited Share Price Other OTC
Equities
SPHRY
US8555631022
Pharmaceuticals
Sales 2022 | 5.16M 3.43M 272M | Sales 2023 | 4.21M 2.8M 222M | Capitalization | 127M 84.56M 6.7B |
---|---|---|---|---|---|
Net income 2022 | -16M -10.63M -842M | Net income 2023 | -15M -9.97M -790M | EV / Sales 2022 | 50.5 x |
Net cash position 2022 | 41.73M 27.73M 2.2B | Net cash position 2023 | 26.91M 17.88M 1.42B | EV / Sales 2023 | 23.8 x |
P/E ratio 2022 |
-18.5
x | P/E ratio 2023 |
-7.75
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.55% |
Managers | Title | Age | Since |
---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | 01-07 |
Justin Cahill
DFI | Director of Finance/CFO | - | 02/04/23 |
Tony Eglezos
PRN | Corporate Officer/Principal | - | 11/08/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Davies
BRD | Director/Board Member | - | 31/03/22 |
Robert Thomas
CHM | Chairman | 79 | 03/12/13 |
David McIntyre
BRD | Director/Board Member | 53 | 29/02/20 |
1st Jan change | Capi. | |
---|---|---|
+54.71% | 815B | |
+44.25% | 654B | |
-6.51% | 354B | |
+22.06% | 337B | |
+10.45% | 302B | |
+18.45% | 247B | |
+2.09% | 229B | |
+13.03% | 219B | |
+9.28% | 171B |